• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number TGMR404020
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Hypoxia (1918)
Date of Event 06/21/2021
Type of Reportable Event Death
Additional Manufacturer Narrative
The following additional devices were investigated as it is not known which device, if any, caused or contributed to the patient death: according to the gore® tag® conformable thoracic stent graft with active control system instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to: respiratory failure, embolization and death.
 
Event or Problem Description
The following information was reported to gore: on (b)(6) 2021 a patient was undergoing treatment of an ascending aortic aneurysm as a subject in the ssb 1102 clinical study.The procedure included the use of four gore® tag® conformable thoracic stent grafts with active control system.A gore® dryseal flex introducer sheath was used for access.During the procedure a series of adverse events occurred which led to eventual intraprocedural death.The physician stated the following: ¿in summary, i believe she suffered a series of stresses that cumulatively resulted in her arrest when she became hypoxemic during the reintubation event.The series of stressed included the intermittent hypotension from the wire, treated with pressors for several hours.Her left pelvis/leg were ischemic for about 3.5 hours.The difficulty establishing distal seal in the dta, the left femoral cut-down all caused prolongation of the operation.She had an acute bleed from the access site complication, which although immediately recognized and treated was yet another hit.After all these events, i suspect that her hypoxemia exhausted her physiologic reserve and she coded.The device performed as anticipated and there were no evident technical complications with the device that i am aware of.I believe this was a procedure related event and not a device related event.We are awaiting the autopsy results to determine if there is any alternative explanation for her code and to assess her brain for stroke.Given the acuity from any event and her death, i am unsure if the autopsy will be revealing for stroke.¿ the physician also stated the access injury was not related to the gore sheath.
 
Additional Manufacturer Narrative
H.6.Results code 1: 213: a review of the manufacturing records for the devices verified the lots met all pre-release specifications.D.10.The following additional devices were investigated: tgmr404020 udi: (b)(4) sn# (b)(6).Tgm454515 udi: (b)(4) sn# (b)(6).Tgmr404020 udi: (b)(4) sn# (b)(6).
 
Additional Manufacturer Narrative
Additional information from study center indicated that the devices were not responsible for patient death.The previous report is hereby retracted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
heidi inskeep
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12132541
Report Number2017233-2021-02143
Device Sequence Number4180238
Product Code MIH
UDI-Device Identifier00733132646852
UDI-Public00733132646852
Combination Product (Y/N)N
Initial Reporter StateWA
Initial Reporter CountryUS
PMA/510(K) Number
P040043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 02/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/17/2024
Device Model NumberTGMR404020
Device Catalogue NumberTGMR404020
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Received by Manufacturer 06/21/2021
Supplement Date Received by Manufacturer10/25/2021
06/08/2021
Initial Report FDA Received Date07/07/2021
Supplement Report FDA Received Date10/25/2021
02/04/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/18/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H.10./11.
Outcome Attributed to Adverse Event Death;
Patient Age79 YR
Patient SexFemale
Patient Weight70 KG
-
-